# Prevention of Recurrent Venous Thromboembolism (PREVENT)

> **NCT00000614** · PHASE3 · COMPLETED · sponsor: **National Heart, Lung, and Blood Institute (NHLBI)**

## Conditions studied

- Cardiovascular Diseases
- Heart Diseases
- Peripheral Vascular Diseases
- Thromboembolism
- Vascular Diseases
- Venous Thromboembolism

## Interventions

- **DRUG:** warfarin

## Key facts

- **NCT ID:** NCT00000614
- **Lead sponsor:** National Heart, Lung, and Blood Institute (NHLBI)
- **Sponsor class:** NIH
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1998-09
- **Primary completion:** —
- **Final completion:** 2004-08
- **Target enrollment:** — (—)
- **Last updated:** 2016-03-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00000614

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00000614, "Prevention of Recurrent Venous Thromboembolism (PREVENT)". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00000614. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*